Navidea Biopharmaceuticals To Report Preliminary 2014 Revenue And Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference February 9

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), today announced that the Company will report preliminary fourth quarter and full year 2014 revenues and provide a business update before market open on Monday, February 9, 2015. In addition, Rick Gonzalez, Chief Executive Officer, will present at the 17th Annual BIO CEO and Investor Conference at 10:00 am EST on February 9, 2015.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC